Access to Medication and Drug Company Sales Practices: Setting Priorities for Critique and Advocacy
Online Access
http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Access+to+medication+and+drug+company+sales+practices:+setting+priorities+for+critique+and+advocacy&title=American+Journal+of+Bioethics+&volume=3&issue=3&spage=61&date=2003-06&au=Seiler,+Naomihttps://dx.doi.org/10.1162/15265160360706642
http://hdl.handle.net/10822/1000110
Date
2016-01-09Identifier
oai:repository.library.georgetown.edu:10822/1000110doi:10.1162/15265160360706642
American Journal of Bioethics 2003 Summer; 3(3): 61
http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Access+to+medication+and+drug+company+sales+practices:+setting+priorities+for+critique+and+advocacy&title=American+Journal+of+Bioethics+&volume=3&issue=3&spage=61&date=2003-06&au=Seiler,+Naomi
http://dx.doi.org/10.1162/15265160360706642
http://hdl.handle.net/10822/1000110
DOI
10.1162/15265160360706642ae974a485f413a2113503eed53cd6c53
10.1162/15265160360706642